- €439.10m
- €265.67m
- $487.32m
- 70
- 84
- 22
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 137 | 123 | 90.9 | 156 | 487 |
Cost of Revenue | |||||
Gross Profit | 89.8 | 75.8 | 45.8 | 92 | 201 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 121 | -16.1 | 88.5 | -157 | 438 |
Operating Profit | 15.5 | 139 | 2.38 | 313 | 49.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.87 | 93 | 13.6 | 321 | 76.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.2 | 92 | 11.6 | 320 | 72 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -13.2 | 91.9 | 11.6 | 320 | 72 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.2 | 91.9 | 11.6 | 320 | 72 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.604 | -0.076 | -0.248 | 1.91 | 1.2 |
Dividends per Share |